[Left Mouse Button And Drag To Manually Rotate The Molecule]
Fatigue is the most commonly reported symptom in patients with cancer, with a prevalence of over 60% reported in the majority of studies. Clinical trials that assessed pharmacologic agents for the treatment of cancer related fatigue include Acetyl L Carnitine(ALC) (Carroll, 2007).
Stimulates natural killer cells
Immune enhancer
Lentinan does not attack cancer cells directly, but produces its antitumor effect by activating different immune responses in the host. Lentinan has displayed various kinds of immune activities in both animals and in humans.